About this trial
The purpose of The EXPAND study is to develop and pilot a pharmacist led model of medication delivery. Following a co-design phase, patients may receive injections at satellite pharmacies by a licensed pharmacist. The acceptability, appropriateness, and feasibility of this approach and standard in clinic administration by a nurse will be assessed.
Eligibility criteria
Qualifiers
18 years of age and older
diagnosed with HIV by approved HIV screen and confirmation test
currently on CAB+RPV LA every 4 or 8 weeks
has received at least two doses of CAB+PRV LA
Disqualifiers
individuals who are unable or unwilling to adhere to the study protocol
unable to speak/comprehend English
insurance coverage for medication through medical benefit
Trial design
Treatments tested in this trial
- Model of care delivery for long-acting injectable ART
Treatment groups
Locations
Sponsors and collaborators
MetroHealth Medical Center
Lead sponsor
ViiV Healthcare
Collaborator